View this article online: https://www.carriermanagement.com/features/2022/08/10/239065.htm
I Registered the Term Nuclear Verdicts®. Here’s Why.
In October 2019, a Philadelphia jury delivered an $8 billion verdict against Johnson & Johnson for its improper marketing of the antipsychotic drug Risperdal as a treatment for some mental health disorders in children.
Executive Summary
While a lot of insurance professionals toss around the phrase "Nuclear Verdicts," not everyone knows that Robert Tyson, the author of "Nuclear Verdicts®: Defending Justice for All," trademarked the term. In this contribution to Carrier Management's "What I Care About" series of articles, Tyson explains why and describes some innovations his law firm is working on the help insurers do something about Nuclear Verdicts®. Executive SummaryWhile a lot of insurance professionals toss around the phrase “Nuclear Verdicts,” not everyone knows that Robert Tyson, the author of “Nuclear Verdicts®: Defending Justice for All,” trademarked the term. In this contribution to Carrier Management’s “What I Care About” series of articles, Tyson explains why and describes some innovations his law firm is working on the help insurers do something about Nuclear Verdicts®.
In May 2019, a California jury issued a $2 billion verdict against Monsanto after finding that its Roundup weed killer caused a couple‘s cancer.
